![James McNulty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James McNulty
Finanzdirektor/CFO bei
HEDGEPATH PHARMACEUTICALS INC
Vermögen: 168 132 $ am 31.05.2026
Profil
Mr. James A. McNulty, CPA, is an Independent Director at Lunai Bioworks, Inc., a Chief Financial Officer, Secretary & Treasurer at Inhibitor Therapeutics, Inc., a Chief Financial Officer at MIRALOGX LLC, a Chief Financial Officer at Repurposed Therapeutics, Inc., a Director-Tampa Bay Chapter at Financial Executives International, a Member at Florida Institute of Certified Public Accountants and a Member at The American Institute of Certified Public Accountants.
He is on the Board of Directors at Lunai Bioworks, Inc. Mr. McNulty was previously employed as a Chief Financial Officer by MIRA Pharmaceuticals, Inc., a Lead Independent Director by CV Sciences, Inc., a Chief Executive Officer by MyMD Pharmaceuticals, Inc. /Old/, a Chief Financial Officer by BioVest International, Inc., a Secretary & Treasurer by Accentia Biopharmaceuticals, Inc., a Chief Operating & Financial Officer by American Prescription Providers, Inc., a Chief Financial Officer by Hopkins Capital Group, a Treasurer & Senior Vice President by BioDelivery Sciences International, Inc., a Chief Financial Officer by Star Scientific, Inc., a Co-Founder by Pender, McNulty & Newkirk, a Chief Financial Officer by CeleXx Corp., a Chief Executive & Financial Officer by Defender Pharmaceuticals, Inc., a Founder by McNulty & Co., a Founder by McNulty, Garcia & Ortiz PA, a Chief Financial Officer by RetinaPharma Technologies, Inc., a Chief Financial Officer by TEAMM Pharmaceuticals, Inc., and a Chief Financial Officer by Telomir Pharmaceuticals, Inc. He also served on the board at Quantum Technology Sciences, Inc. He received his undergraduate degree from the University of South Florida.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.03.2025 | 1.946.135 ( 1,13 % ) | 163 475 $ | 31.05.2026 | |
LUNAI BIOWORKS, INC. 0,03 % | 10.04.2026 | 1.512 ( 0,03 % ) | 4 657 $ | 31.05.2026 |
Aktive Positionen von James McNulty
| Unternehmen | Position | Beginn |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Finanzdirektor/CFO | 13.12.2022 |
| LUNAI BIOWORKS INC. | Direktor/Vorstandsmitglied | 14.10.2024 |
Repurposed Therapeutics, Inc. | Finanzdirektor/CFO | - |
Financial Executives International
 Financial Executives International Miscellaneous Commercial ServicesCommercial Services Operates association for treasurers, controllers, tax executives, and others in financial services | Corporate Officer/Principal | - |
Florida Institute of Certified Public Accountants
 Florida Institute of Certified Public Accountants The Florida Institute of Certified Public Accountants (FICPA) is a professional organization representing certified public accountants and accounting professionals in public accounting, private industry, government, and education. The private company is based in Tallahassee, FL. FICPA provides services such as continuing professional education, career development programs, leadership opportunities, advocacy, and resources for all career stages. The organization offers educational resources including conferences, online courses, and specialized programs on industry topics, and administers the mandatory AICPA peer review program to ensure quality control in accounting and auditing firms. FICPA also runs initiatives like the corporate membership program and the "Bridge to CPA" pilot program, which offers tuition-free, fully online pathways for future CPAs. Advocacy efforts include monitoring legislation, organizing events, and publishing updates on tax and regulatory matters. The organization promotes volunteerism and maintains 22 local chapters statewide for networking, education, philanthropy, and leadership development. Members have access to career resources such as job postings, scholarships, exam preparation discounts, and a members-only portal. Deborah Curry has been the CEO of the company since 2011. | Corporate Officer/Principal | - |
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James McNulty
| Unternehmen | Position | Ende |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.01.2024 |
| MIRA PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 01.04.2023 |
| CV SCIENCES, INC. | Direktor/Vorstandsmitglied | 27.07.2020 |
| ░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von James McNulty
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
50
Beziehungen ersten Grades
25
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 25 |
|---|---|
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures a variety of pharmaceutical products | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
CeleXx Corp.
 CeleXx Corp. Information Technology ServicesTechnology Services Provides hardware and software integration & learning management integration | Technology Services |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Health Technology |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceuticals | Health Technology |
CV Sciences, Inc.
 CV Sciences, Inc. Pharmaceuticals: OtherHealth Technology Manufactures, markets and sells products containing hemp oil | Health Technology |
Lunai Bioworks, Inc.
 Lunai Bioworks, Inc. BiotechnologyHealth Technology Operates as preclinical stage biotechnology company developing technologies and therapies for HIV, HBV and cancer | Health Technology |
American Prescription Providers, Inc.
 American Prescription Providers, Inc. Drugstore ChainsRetail Trade Retails pharmaceutical products | Retail Trade |
The American Institute of Certified Public Accountants
The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants | Commercial Services |
TEAMM Pharmaceuticals, Inc.
 TEAMM Pharmaceuticals, Inc. Medical DistributorsDistribution Services Markets and sells prescription pharmaceutical products | Distribution Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Financial Executives International
Financial Executives International Miscellaneous Commercial ServicesCommercial Services Operates association for treasurers, controllers, tax executives, and others in financial services | Commercial Services |
Florida Institute of Certified Public Accountants
Florida Institute of Certified Public Accountants The Florida Institute of Certified Public Accountants (FICPA) is a professional organization representing certified public accountants and accounting professionals in public accounting, private industry, government, and education. The private company is based in Tallahassee, FL. FICPA provides services such as continuing professional education, career development programs, leadership opportunities, advocacy, and resources for all career stages. The organization offers educational resources including conferences, online courses, and specialized programs on industry topics, and administers the mandatory AICPA peer review program to ensure quality control in accounting and auditing firms. FICPA also runs initiatives like the corporate membership program and the "Bridge to CPA" pilot program, which offers tuition-free, fully online pathways for future CPAs. Advocacy efforts include monitoring legislation, organizing events, and publishing updates on tax and regulatory matters. The organization promotes volunteerism and maintains 22 local chapters statewide for networking, education, philanthropy, and leadership development. Members have access to career resources such as job postings, scholarships, exam preparation discounts, and a members-only portal. Deborah Curry has been the CEO of the company since 2011. | |
RetinaPharma Technologies, Inc.
 RetinaPharma Technologies, Inc. Medical DistributorsDistribution Services Develops products for the prevention, treatment, and diagnosis | Distribution Services |
Pender, McNulty & Newkirk | |
McNulty & Co.
 McNulty & Co. Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
McNulty, Garcia & Ortiz PA | |
Quantum Technology Sciences, Inc.
 Quantum Technology Sciences, Inc. Aerospace & DefenseElectronic Technology Designs tactical geophysical technology | Electronic Technology |
Hopkins Capital Group
 Hopkins Capital Group Investment ManagersFinance Hopkins Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Repurposed Therapeutics, Inc. | |
MyMD Pharmaceuticals (Florida), Inc.
 MyMD Pharmaceuticals (Florida), Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops therapeutic platforms | Health Technology |
Defender Pharmaceuticals, Inc.
 Defender Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of pharmaceuticals | Health Technology |
MIRA Pharmaceuticals, Inc.
 MIRA Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Develops and sells new molecular synthetic THC for the treatment of adult patients with anxiety and cognitive decline | Health Technology |
Telomir Pharmaceuticals, Inc.
 Telomir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops a novel small molecule as the first regulator of telomere length and genomic stability | Health Technology |
